Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

An Investigation on the Effect of Age and BMI on the Pharmacokinetics of Transdermal Granisetron.

Next Previous
Trial Profile

An Investigation on the Effect of Age and BMI on the Pharmacokinetics of Transdermal Granisetron.

Status: Completed
Phase of Trial: Phase I

Latest Information Update: 29 Jul 2024

Price :
$35 *
Note:
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Granisetron (Primary)
  • Indications Nausea and vomiting
  • Focus Pharmacokinetics
  • Sponsors Kyowa Kirin

Most Recent Events

  • 09 Jul 2013 Outcomes for part 2 of this trial presented at the Multinational Association for Supportive Care in Cancer (MASCC) 2013 Annual Meeting, according to a ProStrakan media release.
  • 08 Oct 2009 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
  • 08 Oct 2009 Actual end date (Sep 2009) added as reported by ClinicalTrials.gov.

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top